Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Withdrawn 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 4Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Endocrine 1Breast 1

Conditions

Cardiovascular Diseases 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × High-Intensity Interval Training × Breast × Clear all
NCT05786014 2025-06-12

The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies

University of Virginia

Phase NA Completed
24 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡